Research and Markets: Drug Cartridge-based Syringes and Injectors: Devices, Therapeutics, Players, Markets and Prospects
In the past two decades, drug delivery has become a major factor in the advancement of the quality of life and a key factor in the business success of pharmaceutical companies. During this time, syringes and injectors have evolved considerable to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs. Prefilled cartridges offer several advantages over traditional packaging in vials. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling.
Highlights
- Provides detailed analysis of cartridge-based syringe and injector market segments, market dynamics and market demographics
- Analyzes therapeutic demand drivers and evaluates commercial cartridge-based syringe and injector products in eleven major therapeutic segments
- Examines design factors, material selection issues, technologies and market development issues
- Charts product data and forecasts to 2015
- Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations
Key Topics Covered:
Executive Summary
Injectable Drug Market Dynamics
- The Injectable Drug Ecosystem
- Drug Class, Indications and Demand
- Specialty Injection Device Demand Drivers
- - Chronic Conditions and
Self-Administration - - Shifting Patient Demographics
- - Drug Economics, Safety and Compliance
- - Biosimilars and Injectable Generics
- Competitive Landscape
- Technology Market Drivers
Cartridge System Design Factors
- Standard Device Platforms
- Single Dose vs. Multi-Dose Devices
- Disposable Devices
- Reusable Devices
- Lyophilized Drugs & Dual Chamber Cartridges
Cartridge-based Injectables - Product Analysis
- Anticoagulants
- Anticonvulsants
- Antiemetics
- Antihistamines & Catecholamines
- Antivirals
- Bnzodiazepines
- Beta Blockers
- Dopamine Agonists
- Growth Hormones
- Hematopoietics
- Incretin Mimetics
- Insulins
- NSAIDs
- Parathyroid Hormones
- Narcotic Analgesics
- Opioid Antagonists
- Reproductive Hormones
- Triptans
Cartridge-based Injectables - Market Sector Assessments and Forecasts
- Cardiovascular
- Immunology
- Metabolic
- - Diabetes
- - Hormone Deficiency
- - Osteoporosis
- Neurology
- - Epilepsy
- - Migraine
- - Pain Management
- - Parkinson's Disease
- Reproductive Medicine
Market Factors
- Regulatory Considerations
- Patient Preferences
- Strategic Alliances & Partnerships
Market Participant Profiles
For more information visit http://www.researchandmarkets.com/research/7c5761/drug_cartridgebas
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Source:



Advisor News
- DOL proposes new independent contractor rule; industry is ‘encouraged’
- Trump proposes retirement savings plan for Americans without one
- Millennials seek trusted financial advice as they build and inherit wealth
- NAIFA: Financial professionals are essential to the success of Trump Accounts
- Changes, personalization impacting retirement plans for 2026
More Advisor NewsAnnuity News
- F&G joins Voya’s annuity platform
- Regulators ponder how to tamp down annuity illustrations as high as 27%
- Annual annuity reviews: leverage them to keep clients engaged
- Symetra Enhances Fixed Indexed Annuities, Introduces New Franklin Large Cap Value 15% ER Index
- Ancient Financial Launches as a Strategic Asset Management and Reinsurance Holding Company, Announces Agreement to Acquire F&G Life Re Ltd.
More Annuity NewsHealth/Employee Benefits News
- SENATOR ALVORD PUSHES BACK ON CONSTANT COST INCREASES OF HEALTH INSURANCE WITH FULL BIPARTISAN SUPPORT
- Queensbury details exemptions to lower property tax
- Expanded Affordable Care Act subsidies – now expired – drove major increases in marketplace health insurance enrollment across key groups: Johns Hopkins Bloomberg School of Public Health
- New Insurance Study Findings Have Been Reported from University of South Carolina (Brokering a new path: navigating administrative burdens in the health insurance Marketplaces): Insurance
- Medicaid disenrollment spikes at age 19, study finds: University of Chicago
More Health/Employee Benefits NewsLife Insurance News